Acyl‐CoA binding proteins: Multiplicity and function
- 1 September 1996
- Vol. 31 (9) , 895-918
- https://doi.org/10.1007/bf02522684
Abstract
The physiological role of long‐chain fatty acyl‐CoA is thought to be primarily in intermediary metabolism of fatty acids. However, recent data show that nM to μM levels of these lipophilic molecules are potent regulators of cell functionsin vitro. Although long‐chain fatty acyl‐CoA are present at several hundred μM concentration in the cell, very little long‐chain fatty acyl‐CoA actually exists as free or unbound molecules, but rather is bound with high affinity to membrane lipids and/or proteins. Recently, there is growing awareness that cytosol contains nonenzymatic proteins also capable of binding long‐chain fatty acyl‐CoA with high affinity. Although the identity of the cytosolic long‐chain fatty acyl‐CoA binding protein(s) has been the subject of some controversy, there is growing evidence that several diverse nonenzymatic cytosolic proteins will bind long‐chain fatty acyl‐CoA. Not only does acyl‐CoA binding protein specifically bind medium and long‐chain fatty acyl‐CoA (LCFA‐CoA), but ubiquitous proteins with multiple ligand specificities such as the fatty acid binding proteins and sterol carrier protein‐2 also bind LCFA‐CoA with high affinity. The potential of these acyl‐CoA binding proteins to influence the level of free LCFA‐CoA and thereby the amount of LCFA‐CoA bound to regulatory sites in proteins and enzymes is only now being examined in detail. The purpose of this article is to explore the identity, nature, function, and pathobiology of these fascinating newly discovered long‐chain fatty acyl‐CoA binding proteins. The relative contributions of these three different protein families to LCFA‐CoA utilization and/or regulation of cellular activities are the focus of new directions in this field.Keywords
This publication has 210 references indexed in Scilit:
- Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptakeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding proteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Carnitine palmitoyltransferase activities: Effects of serum albumin, acyl-CoA binding protein and fatty acid binding proteinMolecular and Cellular Biochemistry, 1994
- Acyl-CoA-binding protein/diazepam-binding inhibitor gene and pseudogenesJournal of Molecular Biology, 1992
- Three-dimensional structure in solution of acyl-coenzyme A binding protein from bovine liverJournal of Molecular Biology, 1992
- Diazepam binding inhibitor processing in the rhesus monkey brain: An immunocytochemical studyJournal of Chemical Neuroanatomy, 1992
- The species of acyl-CoA in subcellular fractions of type II cells isolated from adult rat lung and their incorporation into phosphatidic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Human fetal liver fatty acid binding proteins. Role on glucose-6-phosphate dehydrogenase activityBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assayBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Binding of acyl-CoA to liver fatty acid binding protein: effect on acyl-CoA synthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987